1974
DOI: 10.1203/00006450-197405000-00002
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Age on ortho-Hydroxyphenylacetic Acid Excretion in Phenylketonuria and Its Genetic Variants

Abstract: ExtractExcretion in urine of o-hydroxyphenylacetic acid (0-OH-PAA) was measured quantitatively during a 24-hr period in 43 children ranging from 2 weeks to 12 years of age who were affected by different types of hyperphenylalaninemia (20 typical phenylketonuria (PKU) 7 atypical PKU, and 16 mild forms according to the classification of Auerbach et 01.); 28 out of the 33 cases diagnosed at birth in the course of a screening program were examined before reaching 3 months of age. Phenylpyruvic acid (PPA) excretion… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

1977
1977
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 12 publications
(6 reference statements)
0
5
0
Order By: Relevance
“…Rey et al (1974) first described the influence of age on excretion of OHPAA in children with PKU and found adult threshold values only after 2 years. Accordingly, metabolic data of PKU children older than 2 years conform with respective findings in juvenile patients (Langenbeck et al 1980(Langenbeck et al , 1992, and phe tolerance at 10 years of age can be predicted reliably from the respective data at 2 years (van Spronsen et al 2009).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Rey et al (1974) first described the influence of age on excretion of OHPAA in children with PKU and found adult threshold values only after 2 years. Accordingly, metabolic data of PKU children older than 2 years conform with respective findings in juvenile patients (Langenbeck et al 1980(Langenbeck et al , 1992, and phe tolerance at 10 years of age can be predicted reliably from the respective data at 2 years (van Spronsen et al 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Whether delayed maturation of phe transaminase, as suggested by Rey et al (1974), and/or delayed maturation of the pAH transporter explains the data could be decided by knowledge of phe metabolite blood levels. However, we only know of three such observations: Partington and Vickery (1974), using the enol-borate method for quantifying PPA, found in a 3-week-old infant plasma PPA levels in the range seen in older children.…”
Section: Discussionmentioning
confidence: 99%
“…Many methods, including ferric chloride assay, electrochemical sensing, chemiluminescence detection, HPLC-MS, GC-MS, have been reported to detect PPA in urine. [10][11][12][13][14][15][16] However, although with high sensitivity and excellent specificity, these methods are suffered from the complicated and laborious procedures, cost and time consumption, which is not conducive to home-based diagnosis and can impose a huge financial burden on families requiring long-time monitoring. [17] Consequently, it is urgent to develop a low-cost, simple, rapid, and sensitive method for PPA detection.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, developing methods to quantificationally detect PPA in urine is an ideal option. Many methods, including ferric chloride assay, electrochemical sensing, chemiluminescence detection, HPLC–MS, GC–MS, have been reported to detect PPA in urine [10–16] . However, although with high sensitivity and excellent specificity, these methods are suffered from the complicated and laborious procedures, cost and time consumption, which is not conducive to home‐based diagnosis and can impose a huge financial burden on families requiring long‐time monitoring [17] .…”
Section: Introductionmentioning
confidence: 99%
“…Earlier reports [3,15] claimed that in older children the metabolites ofphe are excreted only when phe levels in blood rise above a so-called "threshold" of 0.4-0.9 mM (7-15 mg/100 ml). Two recent papers provide evidence that not only untreated patients with PKU variants (phe < 1.20 mM) but also patients under the more stringent therapeutic standards (0.50mM phe) of Bickel [1] are exposed to abnormally elevated concentrations of the metabolites of phe.…”
Section: Introductionmentioning
confidence: 99%